The board of directors of China Traditional Chinese Medicine Co. Limited informed the shareholders of the company and potential investors that based on the preliminary assessment by the company's management with reference to the unaudited consolidated management accounts of the Group for the six months ended June 30, 2014, the Group is expected to record a significant increase in consolidated net profit attributable to the shareholders for the six months ended June 30, 2014 as compared with the consolidated net profit attributable to the shareholders of approximately HKD 78.5 million for the six months ended June 30, 2013. The Board considers that the expected improvement in the overall results of the Group for the six months ended June 30, 2014 as compared with the corresponding period in 2013 was mainly attributable to the consolidation of the financial results of Tongjitang Chinese Medicines Company (which was acquired by the company in October 2013) and its subsidiaries.